Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Apr 3, 2023
Trial Information
Current as of November 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new mobile app designed to help transgender and gender diverse individuals improve their voice quality. The researchers believe that using this app might be as effective, or even better, than traditional speech therapy. They will assess how participants feel about their voices and analyze the actual sound of their voices to see if the app really works.
To join the study, participants need to be at least 18 years old, identify as transgender, and be able to read and write in English. It's important that they own an iOS device, like an iPhone or iPad, to use the app. The trial is not yet recruiting participants, but it aims to provide a new, convenient way for individuals to work on their voice in a supportive and accessible manner.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Identify as a transgender individual
- • Be 18 years or older
- • Be able to read and write in English
- • Have an iOS Device
- Exclusion Criteria:
- • Identify as cisgender
- • Experience hoarseness
- • Experiencing any physical pain related to voice use
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Ithaca, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Anais Rameau, MD, MPhil
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials